Abstract:Keywords: <ul><li><a href="/keyword/Antimicrobial+Peptides">antimicrobial peptides</a></li><li><a href="/keyword/Appropriate+Formulation">appropriate formulation</a></li><li><a href="/keyword/Chemical+Modification">chemical modification</a></li><li><a href="/keyword/De+Novo+Design">de novo design</a></li><li><a href="/keyword/Lipopeptide">lipopeptide</a></li><li><a href="/keyword/Pegylation">PEGylation</a></li><li><a href="/keyword/Peptidomimetic">peptidomimetic</a></li><li><a href="/keyword/Prodrug">prodrug</a></li><li><a href="/keyword/Protease+Stability">protease stability</a></li><li><a href="/keyword/Unnatural+Amino+Acid">unnatural amino acid</a></li></ul><h2>References</h2><ul class="rlist separator"><li class="references__item">1. Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15(11), 689–696 (2017).<a href="/servlet/linkout?suffix=B1&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1038%2Fnrmicro.2017.75">Crossref</a>, <a href="/servlet/linkout?suffix=B1&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=28757648">Medline</a>, <a href="/servlet/linkout?suffix=B1&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2sXht1CktLzN">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sommer+MOA%2C+Munck+C%2C+Toft-Kehler+RV%2C+Andersson+DI.+Prediction+of+antibiotic+resistance%3A+time+for+a+new+preclinical+paradigm%3F+Nat.+Rev.+Microbiol.+15%2811%29%2C+689%E2%80%93696+%282017%29.">Google Scholar</a></li><li class="references__item">2. Mansour SC, Pena OM, Hancock RE. Host defense peptides: front-line immunomodulators. Trends Immunol. 35(9), 443–450 (2014).<a href="/servlet/linkout?suffix=B2&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.it.2014.07.004">Crossref</a>, <a href="/servlet/linkout?suffix=B2&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=25113635">Medline</a>, <a href="/servlet/linkout?suffix=B2&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC2cXhtleisb%252FJ">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mansour+SC%2C+Pena+OM%2C+Hancock+RE.+Host+defense+peptides%3A+front-line+immunomodulators.+Trends+Immunol.+35%289%29%2C+443%E2%80%93450+%282014%29.">Google Scholar</a></li><li class="references__item">3. Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 27(4), 323–338 (2019).<a href="/servlet/linkout?suffix=B3&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1016%2Fj.tim.2018.12.010">Crossref</a>, <a href="/servlet/linkout?suffix=B3&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30683453">Medline</a>, <a href="/servlet/linkout?suffix=B3&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXivF2hsw%253D%253D">CAS</a>, <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ghosh+C%2C+Sarkar+P%2C+Issa+R%2C+Haldar+J.+Alternatives+to+conventional+antibiotics+in+the+era+of+antimicrobial+resistance.+Trends+Microbiol.+27%284%29%2C+323%E2%80%93338+%282019%29.">Google Scholar</a></li><li class="references__item">4. Wang J, Dou X, Song J et al. Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med. Res. Rev. 39(3), 831–859 (2019).<a href="/servlet/linkout?suffix=B4&dbid=16&doi=10.4155%2Ffmc-2019-0167&key=10.1002%2Fmed.21542">Crossref</a>, <a href="/servlet/linkout?suffix=B4&dbid=8&doi=10.4155%2Ffmc-2019-0167&key=30353555">Medline</a>, <a href="/servlet/linkout?suffix=B4&dbid=32&doi=10.4155%2Ffmc-2019-0167&key=1%3ACAS%3A528%3ADC%252BC1MXntlGksbY%-Abstract Truncated-

Future prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations

Progress towards the clinical use of antimicrobial peptides: challenges and opportunities

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

Antimicrobial peptides: Opportunities and challenges in overcoming resistance

Antimicrobial Peptides: From Design to Clinical Application

Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Small Molecular Mimetics of Antimicrobial Peptides As a Promising Therapy to Combat Bacterial Resistance.

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design

From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP De- sign and Selectivity

From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity

Beyond Antibiotics: What the Future Holds

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

The evolution of antimicrobial peptide resistance in is severely constrained by random peptide mixtures

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

Antimicrobial peptides with protease stability: progress and perspective